Neutralization of LIGHT ameliorates acute dextran sodium sulphate-induced intestinal inflammation

Immunology

Volumn 128, Issue 3, 2009, Pages 451-458

  Jungbeck, Michaela ^a   Daller, Barbara ^a   Federhofer, Josef ^a   Wege, Anja K ^a   Wimmer, Nadin ^a   Männel, Daniela N ^a   Hehlgans, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

DSS induced intestinal inflammation; LIGHT; Neutralizing antibodies

Indexed keywords

DEXTRAN SULFATE; LIGHT MONOCLONAL ANTIBODY 15B2; LIGHT MONOCLONAL ANTIBODY 9D10; MESSENGER RNA; MONOCLONAL ANTIBODY; TITERMAX GOLD ADJUVANT VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; COLITIS; COLON; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERVENTION STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; COLITIS, ULCERATIVE; COLON; DEXTRAN SULFATE; EPITOPES; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, MESSENGER; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

EID: 70349669242     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03131.x     Document Type: Article

References (22)

1. Harrop JA, McDonnell PC, Brigham-Burke M et al. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 1998 273 : 27548 27556.
2. Mauri DN, Ebner R, Montgomery RI et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 1998 8 : 21 30.
3. Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999 274 : 13733 13736.
4. Zhai Y, Guo R, Hsu TL et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 1998 102 : 1142 1151.
5. Tamada K, Shimozaki K, Chapoval AI et al. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med 2000 6 : 283 289.
6. Shaikh RB, Santee S, Granger SW, Butrovich K, Cheung T, Kronenberg M, Cheroutre H, Ware CF. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol 2001 167 : 6330 6337.
7. Wang J, Anders RA, Wang Y, Turner JR, Abraham C, Pfeffer K, Fu YX. The critical role of LIGHT in promoting intestinal inflammation and Crohn's disease. J Immunol 2005 174 : 8173 8182.
8. Sartor RB. Innate immunity in the pathogenesis therapy of IBD. J Gastroenterol 2003 38 (Suppl. 15 43 7.
9. Sartor RB. Clinical applications of advances in the genetics of IBD. Rev Gastroenterol Disord 2003 3 (Suppl. 1 S9 17.
10. Targan SR, Hanauer SB, van Deventer SJ et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997 337 : 1029 1035.
11. Jungbeck M, Stopfer P, Bataille F, Nedospasov SA, Mannel DN, Hehlgans T. Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation - opposite functions for surface lymphotoxin expressed by T and B lymphocytes. Mol Immunol 2008 45 : 34 41.
12. Scheu S, Alferink J, Potzel T, Barchet W, Kalinke U, Pfeffer K. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J Exp Med 2002 195 : 1613 1624.
13. Hehlgans T, Mannel DN. Recombinant, soluble LIGHT (HVEM ligand) induces increased IL-8 secretion and growth arrest in A375 melanoma cells. J Interferon Cytokine Res 2001 21 : 333 338.
14. Hehlgans T, Muller P, Stopfer P, Mannel DN. Activation of the lymphotoxin-beta receptor induces NFkappaB-dependent interleukin-6 and MIP-2 secretion in mouse fibrosarcoma cells. Eur Cytokine Netw 2003 14 : 103 107.
15. Obermeier F, Dunger N, Deml L, Herfarth H, Scholmerich J, Falk W. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice. Eur J Immunol 2002 32 : 2084 2092.
16. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990 98 : 694 702.
17. Stopfer P, Obermeier F, Dunger N et al. Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis. Clin Exp Immunol 2004 136 : 21 9.
18. Shulman M, Wilde CD, Kohler G. A better cell line for making hybridomas secreting specific antibodies. Nature 1978 276 : 269 270.
19. Morel Y, Truneh A, Sweet RW, Olive D, Costello RT. The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol 2001 167 : 2479 2486.
20. Cohavy O, Zhou J, Granger SW, Ware CF, Targan SR. LIGHT expression by mucosal T cells may regulate IFN-gamma expression in the intestine. J Immunol 2004 173 : 251 258.
21. Watanabe N, Ikuta K, Okazaki K et al. Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice. Dig Dis Sci 2003 48 : 408 414.
22. Granger SW, Butrovich KD, Houshmand P, Edwards WR, Ware CF. Genomic characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis. J Immunol 2001 167 : 5122 5128.